A peer-reviewed study showed full-length spike proteins in the blood of children with myocarditis after receiving COVID shots. Circulation published it this month.[1]
The study involved 16 patients with myocarditis admitted to the Massachusetts General for Children and Boston Children’s Hospital. Results were compared with those from 45 healthy, asymptomatic, age-matched vaccinated control subjects.
The researchers wanted to know why the children developed myocarditis after the mRNA COVID shots.
The study has two disturbing conclusions.
A. Full-length spike proteins present in children with post-COVID vaccine myocarditis.
A notable finding was that markedly elevated levels of full-length spike protein (33.9±22.4 pg/mL), unbound by antibodies, were detected in the plasma of individuals with postvaccine myocarditis, whereas no free spike was detected in asymptomatic vaccinated control subjects.
A fragment of the spike, the S1 protein, aside from the spike protein, was also detected. They were either bound or unbound to an antibody.
The antibody-bound S1 is present in one-third of both myocarditis and non-myocarditis groups. That is expected because the antibodies are supposed to attach to a foreign substance like the spike proteins.
However, those with myocarditis had detectable free and antibody-bound spike proteins up to three weeks after vaccination. That means the free spike proteins are not recognized by the antibodies and can evade the immune system.
Looking at the rate of decline of the S1 antigen in both control and myocarditis groups, it is possible that the antigen could be in the blood for much longer than 21 days.
B. Immunoprofile did not explain why the myocarditis cases have more spike proteins
Immunoprofiling of vaccinated adolescents and young adults revealed that the mRNA vaccine–induced immune responses did not differ between individuals who developed myocarditis and individuals who did not.
They looked at the myocarditis and control group’s white blood cells and neutralizing antibodies and self antibodies and found no difference.
They found no evidence of autoantibody production, concomitant viral infections, or excessive antibody responses to the anti–SARS-CoV-2 mRNA vaccines in postvaccine myocarditis cases.
The difference is in cytokine production.
Cytokine levels in MIS-C and Myocarditis are similar
The Centers for Disease Control defines MIS-C.
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition associated with SARS-CoV-2, that usually occurs 2-6 weeks after a child is infected with SARS-CoV-2.
The child’s SARS-CoV-2 infection may be very mild or have no symptoms at all and may go unrecognized.
MIS-C causes different internal and external body parts to become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal tract.
MIS-C can be serious, even deadly, but most children who are diagnosed with this condition get better with medical care.
In the study, the cytokine profile of myocarditis patients is similar to children with MIS-C. Both have significantly elevated cytokine levels, troponin, a marker of cardiac injury, and C-reactive protein (CRP), a measure of inflammation.
CRP is higher in MIS-C than in myocarditis.
Spike proteins are similar in MIS-C and Post Vaccine Myocarditis
There was no significant difference in the S1 and spike concentrations between the MIS-C and myocarditis groups,
Bottomline: MIS-C and post-vaccine myocarditis are similar in the number of cytokines activated and the presence of spike proteins.
Does it mean that there may be other organs inflamed in those with myocarditis?
In their discussion, the authors theorize that the circulating spike is a “biomarker of immune dysregulation leading to myocarditis rather than a causal agent.”
In the end, the authors recommend continuing the COVID shots to children.
Comment
I’m afraid I have to disagree. Just because they could not determine why the spike protein could evade the immune system does not mean everything should end there.
Just remember, 100% of those who had free spike proteins are the ones who have myocarditis. That’s more than an association.
There must be another mechanism that is waiting to be unraveled. Or is the spike protein from the mRNA different from the SARS-CoV-2 protein?
This is not the first study that shows spike proteins are present in the human body after the COVID gene therapy injection – Pfizer COVID shot makes human liver cells produce SARS-CoV-2 spike DNA
Humans have enzymes that can reverse transcribe RNA from the shots –
The SARS-CoV-2 spike proteins are the most dangerous part of the virus — 13 ways that the SARS-CoV-2 spike protein causes damage.
Their presence in the blood means they can go almost anywhere in the body.
IgG4
The continuous presence of spike proteins in the blood may desensitize the immune system and lead to the generation of the noninflammatory antibody, IgG4.
You can read about it at Pfizer mRNA shots Switch Antibodies to Non-Neutralizing IgG4.
What happens if the IgG4 is high? – Answered at Three Studies Link High IgG4 to Severe COVID-19
Furthermore, having cytokine profiles similar to MIS-C means a smoldering systemic inflammation is present. Who is to say that the inflammation will stop at heart? Or maybe it will if the child suddenly dies.
Anti-spike antibodies?
Here’s a quote from the study.
These findings also suggest that administration of anti-spike antibodies, if spike antigenemia is detected, could potentially prevent or reverse postvaccine myocarditis.
Is that really the purpose of the study? To pave the way for anti-spike antibodies? The drug industry will create a solution to the problem it created.
Is this why they conclude that the spike protein is a harmless biomarker and not a poison that it is?
Risk-Benefit Analysis of the COVID shot
Let’s talk about risk-benefit.
What is the benefit of a vaccine if the infection fatality rate of COVID-19 is 0.0003% for 0-29 years old? [2] I discussed that study from Stanford University in
The Risks of Dying from COVID-19
The European Centre for Disease Prevention and Control looked at ten European Union member countries and evaluated the outcome of COVID-19 in children 0-17 years old. Here are the results.[3]
- 1.2% were hospitalized
- 0.08% required intensive care
- 0.01% died.
How about the risk?
Myocarditis can lead to arrythmias, heart failure, and cardiomyopathy.
Myocardial Inflammation/Myocarditis After COVID-19 mRNA Booster Vaccination was presented to the European Society of Cardiologists in 2022. Their prospective study found the actual incidence of post-vaccination myocardial lesions is 2.8% vs. 0.0035% in retrospective studies.
Another prospective study from Thailand showed an incidence of 2.33%.[4]
Bottomline: The risk of a child dying from COVID-19 – is 0.01 to 0.0003. The risk of myocarditis if given the COVID shot is 2.3 to 2.8%.
Spike Busters
Laboratory studies have shown three over-the-counter substances that can destroy SARS-pCoV-2 spike proteins. All of them are available in the US. I discussed them at
- Nattokinase Degrades the SARS-CoV-2 Spike Protein
- Bromelain and Acetylcysteine Combined Destroy SARS-CoV-2 spike protein
A study should be made to see if these substances can remove the spike proteins in the body. Bound and unbound spike proteins should not last in the human body.
Truth heals. Lies kill. Don’t Get Sick!
Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.
Follow me on Gettr, Truth Social, Gab, Parler, Twitter, Facebook, Follow.it and Telegram.
If you find value in this website, please consider buying a coffee to show your support.
Appendix: The Total load of the spike protein
I made some calculations. The average age of the myocarditis patients in the study is 15 years old. All are male.
- The study [1] found 33.9 picograms of spike protein/ml of plasma
- 33.9 picogram/ml is 0.0000339 microgram/ml
- Average weight of a 15-year-old male American is 105-125 lbs (47.62-56.70 Kg).
- Estimated Blood volume of a 120 lb male – 3810 mL.
- Plasma is 55% of blood volume – 3810 x 0.05 = 2095.5 ml
2095.5 ml x 0.0000339 microgram = 0.07 micrograms of SARS-CoV-2 spike protein in the blood of a 15-year-old with myocarditis due to the mRNA shot.
Related:
- Dr. Clare Craig exposes the twisted Pfizer COVID trial for babies and young children
- In silico study may explain the rise of hepatitis among children
- USA study: Adults and children with the Omicron variant have milder COVID-19
- COVID-19 in children 0-17 years old have a low risk of death and hospitalization
- Children 5-11 Years Old have Mild COVID-19
- Asymptomatic or mild symptomatic COVID-19 elicits effective and long-lasting antibody responses in children and adolescents
- More than 50% of vaccinated athletes with Myocarditis
- COVID jabs increased Risk of Myocarditis Deaths for ALL Ages
- Multiple areas of brain necrosis and myocarditis after the COVID-19 vaccine
- Israel study: No increased incidence of myocarditis with COVID-19
- Thai study shows a whopping 1,660 myocarditis cases per 100K COVID injections
- Autopsy of a soldier who died of myocarditis after Pfizer COVID vaccination
- A professional athlete who died of fulminant myocarditis after the Moderna jab
- Myocarditis by age, sex and COVID shot
- Circulation: Myocarditis related to COVID-19 shots in teenagers and young adults
- Myocarditis after mRNA Vaccination in the Military
References:
- Yonker LM et al. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine myocarditis. Circulation. 2023 Jan 4. doi: 10.1161/CIRCULATIONAHA.122.061025. Epub ahead of print. PMID: 36597886.b
- Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies.
- Bundle N, Dave N, Pharris A, Spiteri G, Deogan C, Suk JE; Study group members. COVID-19 trends and severity among symptomatic children aged 0-17 years in 10 European Union countries, 3 August 2020 to 3 October 2021. Euro Surveill. 2021 Dec;26(50):2101098. doi: 10.2807/1560-7917.ES.2021.26.50.2101098. PMID: 34915968; PMCID: PMC8728490.
- Mansanguan, S.; Charunwatthana, P.; Piyaphanee, W.; Dechkhajorn, W.; Poolcharoen, A.; Mansanguan, C. Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Trop. Med. Infect. Dis. 2022, 7, 196.
© 2018 – 2023 Asclepiades Medicine, LLC. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment
As an Amazon Associate, I earn from qualifying purchases.